Related Experiment Video
Updated: Apr 16, 2026

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
Published on: June 20, 2025
Changes in Pulmonary Function and Controlled Ventilation-High Resolution CT of Chest After Antibiotic Therapy in
Shahid I Sheikh1, Frederick R Long, Robert Flucke
1Departments of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA, Shahid.Sheikh@nationwidechildrens.org.
Insights
Infant pulmonary function tests (IPFT) and controlled ventilation-high resolution computed tomography (CV-HRCT) objectively measure lung disease improvement in infants with cystic fibrosis (CF) after antibiotic treatment. These methods confirm positive changes following intravenous antibiotic therapy in early CF lung disease.
Area of Science:
- Pediatric Pulmonology
- Medical Imaging
- Respiratory Medicine
Background:
- Infants with cystic fibrosis (CF) experience early, progressive lung disease, often asymptomatic.
- Infant pulmonary function tests (IPFT) and controlled ventilation-high resolution computed tomography (CV-HRCT) can detect early, asymptomatic lung disease in infants.
- The ability of these objective measures to track changes after interventions is not well-established.
Purpose of the Study:
- To evaluate the usefulness of IPFT and CV-HRCT in detecting lung disease changes in infants with early CF.
- To assess the impact of intravenous (IV) antibiotic therapy on lung disease in infants with CF using objective measures.
Main Methods:
- A retrospective comparison of IPFT and CV-HRCT data from infants with early CF-related lung disease before and after 2 weeks of IV antibiotics.
- CV-HRCT images were analyzed using the modified Brody scoring system.
- Data from 21 infants, with a mean age of 85.2 ± 47.6 weeks, were analyzed.
Main Results:
- Significant improvements were observed in IPFT measures, including % predicted FEV(0.5) (+13.5%), %FEF(25-75) (+30.2%), %RV/TLC (-11.2%), and %FRC/TLC (-4.5%).
- Total Brody scores on CV-HRCT significantly improved from a median of 10 to 5.
- Specific CV-HRCT scores for airway wall thickening, air trapping, and parenchymal opacities also showed significant improvement.
Conclusions:
- IPFT and CV-HRCT serve as objective tools to measure lung disease improvement in infants with CF.
- These methods demonstrate efficacy in assessing treatment response to antibiotics in pediatric CF patients.
- The findings support the use of IPFT and CV-HRCT for monitoring therapeutic interventions in early CF lung disease.
Background:
Infants with cystic fibrosis (CF) develop early progressive lung disease which may be asymptomatic. Infant pulmonary function tests (IPFT) and controlled ventilation-high resolution computed tomography (CV-HRCT) of chest can detect early asymptomatic lung disease. It is not well established that these objective measures can detect changes in lung disease after clinical interventions.
Objective:
The purpose of this study was to evaluate usefulness of IPFT and CV-HRCT to detect changes in lung disease after intravenous (IV) antibiotic therapy in infants with early CF-related lung disease.
Study Design:
IPFTs and CV-HRCT done before and after 2 weeks of IV antibiotics in infants at our institution over the last 12 years were compared. CV-HRCTs were compared using the modified Brody scoring system.
Results:
The sample included 21 infants, mean age 85.2 ± 47.6 weeks. Mean change in weight was 0.4 ± 0.38 kg (p = 0.001). Significant changes in IPFT included mean % predicted FEV(0.5) (+13.5 %, p = 0.043), mean %FEF(25-75) (+30.2 %, p = 0.008), mean %RV/TLC (-11.2 %, p = 0.008), and mean %FRC/TLC (-4.5 %, p = 0.001). Total Brody scores improved from a median of 10 to 5 (p < 0.001) as did mean scores for airway wall thickening (p = 0.050), air trapping (p < 0.001), and parenchymal opacities (p = 0.003).
Conclusion:
IPFT and CV-HRCT can be used as objective measures of improvement in lung disease for infants with CF treated with antibiotics.
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Chest Physiotherapy
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Radiological Investigation II: MRI and Ventilation Perfusion Scan
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...

